dc.contributor.author |
Lomakin Y. |
|
dc.contributor.author |
Kaminskaya A. |
|
dc.contributor.author |
Stepanov A. |
|
dc.contributor.author |
Shmidt A. |
|
dc.contributor.author |
Gabibov A. |
|
dc.contributor.author |
Belogurov A. |
|
dc.date.accessioned |
2020-01-15T20:52:25Z |
|
dc.date.available |
2020-01-15T20:52:25Z |
|
dc.date.issued |
2019 |
|
dc.identifier.issn |
0007-4888 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/155483 |
|
dc.description.abstract |
© 2019, Springer Science+Business Media, LLC, part of Springer Nature. A system for detection of malignantly transformed cells, including follicular lymphoma Bcells, was developed and experimentally validated. The system is based on the use of bacteriophages carrying exposed ligands for pathogenic B-cell receptors. The efficiency of binding to target cells is several times higher than in systems with chemically synthesized biotinylated peptides. The new method is proposed as a noninvasive diagnostic test for mapping B-cell lymphoma and for determining the specificity of B-cell receptors and high-throughput combinatorial selection of various repertories of B cells. |
|
dc.relation.ispartofseries |
Bulletin of Experimental Biology and Medicine |
|
dc.subject |
B-cell receptor |
|
dc.subject |
flow cytofluorometry |
|
dc.subject |
follicular lymphoma |
|
dc.subject |
M13K07 bacteriophage |
|
dc.subject |
phage display |
|
dc.title |
High-Throughput Platform for B-Cell Screening Based on Fluorescent Phage-Display Technology |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
4 |
|
dc.relation.ispartofseries-volume |
167 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
446 |
|
dc.source.id |
SCOPUS00074888-2019-167-4-SID85073924963 |
|